<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--GCRF-MR_S002340_1</iati-identifier>
  <reporting-org ref="GB-GOV-13" type="10">
   <narrative xml:lang="EN">Department of Business, Energy and Industrial Strategy</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">MRC-FAPESP: New approaches to the treatment of Paracoccidioidomycosis</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Humans have evolved complex and effective ways of fighting infections caused by microbes such as bacteria, parasites, fungi and viruses, the immune system. Sometimes the immune system goes wrong and this can cause serious diseases such as rheumatoid arthritis and diabetes. Our research aims to understand at a molecular level how the cells of the immune system are able to recognise different microbes and the ways in which these cells respond to cause the familiar symptoms of an infection such as fever and tiredness, and to generate specific antibodies that fight the invading microbes. In this project we will study the way in which immune system cells are activated by sugar-binding proteins associated pathogenic yeasts and plants, in particular the way they bind and activate the Toll-like receptors of the innate immune system. Understanding the molecular basis for interactions between these pathogens and immune cells will allow us to carry out a screen to identify new candidate drugs that might be effective therapies for these important diseases.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The over-arching objective of this project is to define the molecular mechanisms by which plant and pathogen lectins interact with the innate immune system. We will exploit this information to screen for new small drug molecules which can potentially be used as therapy in paracoccidioidomycosis.  Aim 1: Determination of the molecular basis of immune modulation by the plant lectin Artin M (1) Charcaterization and quantification of the interaction between Artin M and TLR2, in particular the TLR2 N-linked glycans using biophysical techniques (surface plasmon resonance, isothermal titration calorimetry,. (2) Elucidation of the structure of the Artin M/ TLR2 complex using X-ray crystallography  and cryo electron microscopy (3) Characterisation of the activated heterodimeric conformations of TLR2, TLR1 and TLR6 induced by Artin M binding using  analytical ultracentrifugation and structural analysis Aim 2: Determination of the structure of the lectin paracoccin from the pathogenic yeast Paracoccidioides brasiliensis, the causative agent of paracoccidioidomycosis, the most prevalent systemic mycosis in Latin America. Active  E. coli produced protein will be used for crystallisation and structure determination. Paracoccin is an agonist for TLR2, specifically requiring the 4th N-glycan of TLR2, and also activated TLR4. We will elucidate the activation mechanism at the biophysical and structural level using the experimental approaches outlined in Aim 1. Aim 3: We will set up and validate in silico and medium through put screens to identify small molecule antagonists of immunomodulation mediated by the lectin proteins described. Using experience gained screening for antagonists and agonists of TLR4 we will identify non-competitive inhibitors and activators of TLR2, the target of immune modulation mediated by Artin M and paracoccin.</narrative>
  </description>
  <participating-org ref="GB-GOV-13" role="1" type="10">
   <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
  </participating-org>
  <participating-org role="3" type="90">
   <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">University of Cambridge</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-07-14" type="1"></activity-date>
  <activity-date iso-date="2018-11-22" type="2"></activity-date>
  <activity-date iso-date="2021-07-13" type="3"></activity-date>
  <activity-date iso-date="2022-08-21" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">International Development</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">GCRF</narrative>
   </person-name>
   <email>gcrf@ukri.org</email>
   <website>https://www.ukri.org/</website>
   <mailing-address>
    <narrative xml:lang="EN">Polaris House, Swindon, SN2 1LF</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="BR" percentage="100">
   <narrative xml:lang="EN">Brazil</narrative>
  </recipient-country>
  <recipient-region code="489" percentage="100" vocabulary="1"></recipient-region>
  <sector code="43082" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research/scientific institutions</narrative>
  </sector>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="1">
   <period-start iso-date="2018-04-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="GBP" value-date="2018-07-23">46873.11</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="GBP" value-date="2018-07-23">187872.11</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="GBP" value-date="2018-07-23">142141.08</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="GBP" value-date="2018-07-23">47635.57</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-07-23"></transaction-date>
   <value currency="GBP" value-date="2018-07-23">567045.69</value>
   <description>
    <narrative xml:lang="EN">MRC GCRF Research Grants Award to University of Cambridge</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_S002340_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Cambridge</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/HTTP" url="http://gtr.ukri.org/projects?ref=MR%2FS002340%2F1">
   <title>
    <narrative xml:lang="EN">Abstract/Planned Impact</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-11-22"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.ukri.org/funding/information-for-award-holders/grant-terms-and-conditions/">
   <title>
    <narrative xml:lang="EN">UK Research &amp; Innovation Grant Terms and Conditions</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <conditions attached="1"></conditions>
 </iati-activity>
</iati-activities>
